AI Verdict
ESTA has stronger fundamentals based on our AI analysis.
ESTA vs ESPR Fundamental Comparison
| Metric | ESTA | ESPR |
|---|---|---|
| Revenue | $211.1M | $403.1M |
| Net Income | $-51.1M | $-22.7M |
| Net Margin | -24.2% | -5.6% |
| ROE | -216.9% | N/A |
| ROA | -14.3% | -4.9% |
| Current Ratio | 3.04x | 1.54x |
| Debt/Equity | 10.51x | N/A |
| EPS | $-1.72 | $-0.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ESTA vs ESPR: Frequently Asked Questions
Is ESTA or ESPR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ESTA has stronger fundamentals. ESTA is rated SELL (85% confidence) while ESPR is rated SELL (78% confidence). This is not investment advice.
How does ESTA compare to ESPR fundamentally?
ESTABLISHMENT LABS HOLDINGS INC. has ROE of -216.9% vs Esperion Therapeutics, Inc.'s N/A. Net margins are -24.2% vs -5.6% respectively.
Which stock pays higher dividends, ESTA or ESPR?
ESTA has a dividend yield of N/A or no dividend while ESPR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ESTA or ESPR for long term?
For long-term investing, consider that ESTA has SELL rating with 85% confidence, while ESPR has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ESTA vs ESPR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ESTA vs ESPR, the AI consensus favors ESTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.